Methylprednisolone Completed Phase 2 Trials for Abdominal wall neoplasm / Intestinal Obstruction / Carcinomatosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00332696Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis